CareSuperb COVID-19 Antigen Test Usability

N/A

Waitlist Available

Led By Enrique Villa, MD

Research Sponsored by AccessBio, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one month

Awards & highlights

No Placebo-Only Group

Summary

This trial evaluates the CareSuperb COVID-19 Antigen Home Test, a home kit for detecting COVID-19. It is designed for people aged 14 and older to use themselves, and for adults to test children aged 2 to 13. The test works by identifying a virus protein using a nasal swab.

Eligible Conditions

Coronavirus

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one month

This trial's timeline: 3 weeks for screening, Varies for treatment, and one month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Usability of Quick Reference Instruction

Usability of Test Kit

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: individuals ages 14 years and olderExperimental Treatment1 Intervention

This kit is intended for non-prescription home use with self-collected direct anterior nares swab samples from individuals ages 14 years and older.

Group II: individuals aged 2 to 13 yearsExperimental Treatment1 Intervention

This kit is intended for non-prescription home use with self-collected direct anterior nares swab samples. If the subject is under the age of 14, an adult lay-user will collect the sample.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CareSuperb COVID-19 Antigen Home Test Kit

2022

N/A

~30

Do I qualify?Apply below to find out